Frequency of natural health product use.

<p>Other infrequently used products used included [4 uses each] coenzyme Q10, and flax oil; hawthorn, chondroitin, ginko biloba, ginseng, and vitamin B6; [2 uses each] serrapeptase enzyme, methylsulfonylmethane, cayenne pepper, peppermint, green tea, herbal tea, thai tea, folic acid, and replavite; [1 use each] lutein, white willow bark, motherwort, bilberry, lavender, eucalyptus, wintergreen, menthol, camphor, opti-i-see eye drops, bromelain, turmeric, Echinacea, graviola, rat root plant leaf, banana leaf extract, cranberry supplement, celery herbal, rosemary herbal, seaweed herbal, chamomile tea, carboxymethylcellulose, collagen supplements, vitamin B50 complex, gelatin, and agar.</p

Frequency of natural health products documentation by clinical staff when compared to direct structured interview.

<p>*N represents the number of matched histories of natural health product use (between profession and direct interview).</p><p>**N represents the number matched unique NHP products.</p

Frequency of NHP intake.

<p>Frequency of NHP intake.</p

Proportion of concurrent use of NHP and prescription medication by pharmacy.

<p>Proportion of concurrent use of NHP and prescription medication by pharmacy.</p

Pharmacy standardized patient screening form.

<p>Pharmacy standardized patient screening form.</p

Algorithm to assess the need for suspect products to undergo laboratory analysis.

<p>Algorithm to assess the need for suspect products to undergo laboratory analysis.</p

Proportion with adverse events for those concurrently taking NHP and prescription medication (MED) by pharmacy.

<p>Proportion with adverse events for those concurrently taking NHP and prescription medication (MED) by pharmacy.</p

Flow diagram of Phase I and II Results.

<p>Flow diagram of Phase I and II Results.</p